Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ImmunityBio (IBRX) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for ImmunityBio (IBRX) over the last 9 years, with Q3 2025 value amounting to 3.65.

  • ImmunityBio's Interest Coverage Ratio fell 3322.96% to 3.65 in Q3 2025 from the same period last year, while for Sep 2025 it was 3.61, marking a year-over-year decrease of 2084.38%. This contributed to the annual value of 3.0 for FY2024, which is 683.1% down from last year.
  • Latest data reveals that ImmunityBio reported Interest Coverage Ratio of 3.65 as of Q3 2025, which was down 3322.96% from 4.61 recorded in Q2 2025.
  • Over the past 5 years, ImmunityBio's Interest Coverage Ratio peaked at 2.29 during Q3 2023, and registered a low of 27.23 during Q1 2021.
  • In the last 5 years, ImmunityBio's Interest Coverage Ratio had a median value of 3.74 in 2023 and averaged 8.13.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first crashed by 6211.72% in 2021, then soared by 8316.42% in 2022.
  • Over the past 5 years, ImmunityBio's Interest Coverage Ratio (Quarter) stood at 17.66 in 2021, then surged by 83.16% to 2.97 in 2022, then rose by 9.84% to 2.68 in 2023, then increased by 0.79% to 2.66 in 2024, then crashed by 37.15% to 3.65 in 2025.
  • Its Interest Coverage Ratio was 3.65 in Q3 2025, compared to 4.61 in Q2 2025 and 4.21 in Q1 2025.